US pharmaceutical conglomerate Allergan is reportedly looking to foil Canadian rival Valeant’s plans to acquire the US company, now pursuing a merger of its own.
Allergan is reportedly looking to acquire Ireland’s Shire, news that caused Valeant shares to fall Wednesday.
Experts say the Botox maker could acquire Shire to broaden its …read more
Source: Global Competition Law Blogs